Search
for

    Glossary Estrogen Receptor-Positive Breast Cancer

    cancer type where cells grow due to estrogen binding

    Estrogen Receptor-Positive Breast Cancer (ER+ Breast Cancer) is a type of breast cancer where the cancer cells have receptors that bind to the hormone estrogen. This binding promotes the growth of the cancer cells. Treatments often involve hormone therapies that block estrogen from attaching to these receptors, thereby slowing or stopping the cancer's growth.

    Related Terms

    Research 10 of 1000+

    1. The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis Clinical breast cancer · 2019 · 18 citations
    2. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer Frontiers in Oncology · 2021 · 1 citations
    3. A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer Cancer Research Communications · 2026
    4. Data from A Phase Ib Study of Chemoimmunotherapy with Pegylated Liposomal Doxorubicin and Pembrolizumab in Estrogen Receptor–Positive Metastatic Breast Cancer 2026
    5. Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer JAAD case reports · 2023
    6. Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells International Journal of Molecular Sciences · 2022 · 8 citations
    7. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome Cancer Treatment Reviews · 2023 · 7 citations
    8. Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer Exploration of targeted anti-tumor therapy · 2021 · 2 citations
    9. Aldosterone- and cortisol-cosecreting adrenal adenoma, ovarian hyperthecosis and breast cancer Endocrinology, Diabetes & Metabolism Case Reports · 2020 · 1 citations
    10. 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter Ejc Supplements · 2010
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →